X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES AJANTA PHARMA JUBILANT LIFE SCIENCES/
AJANTA PHARMA
 
P/E (TTM) x 18.5 19.8 93.6% View Chart
P/BV x 4.5 4.5 98.5% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 JUBILANT LIFE SCIENCES   AJANTA PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
AJANTA PHARMA
Mar-18
JUBILANT LIFE SCIENCES/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1871,818 10.3%   
Low Rs651,106 5.9%   
Sales per share (Unadj.) Rs364.3239.5 152.1%  
Earnings per share (Unadj.) Rs6.852.8 13.0%  
Cash flow per share (Unadj.) Rs24.559.5 41.2%  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %2.40-  
Book value per share (Unadj.) Rs164.9230.0 71.7%  
Shares outstanding (eoy) m159.2888.77 179.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.36.1 5.7%   
Avg P/E ratio x18.427.7 66.4%  
P/CF ratio (eoy) x5.124.6 20.9%  
Price / Book Value ratio x0.86.4 12.0%  
Dividend payout %43.80-   
Avg Mkt Cap Rs m20,061129,782 15.5%   
No. of employees `0006.26.8 91.0%   
Total wages/salary Rs m11,0523,765 293.6%   
Avg. sales/employee Rs Th9,383.03,128.4 299.9%   
Avg. wages/employee Rs Th1,786.9554.0 322.5%   
Avg. net profit/employee Rs Th176.3689.7 25.6%   
INCOME DATA
Net Sales Rs m58,03421,258 273.0%  
Other income Rs m191242 78.9%   
Total revenues Rs m58,22421,499 270.8%   
Gross profit Rs m5,7866,584 87.9%  
Depreciation Rs m2,812596 471.8%   
Interest Rs m3,2374 78,956.1%   
Profit before tax Rs m-726,226 -1.2%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m6961,539 45.2%   
Profit after tax Rs m1,0904,686 23.3%  
Gross profit margin %10.031.0 32.2%  
Effective tax rate %-965.924.7 -3,906.9%   
Net profit margin %1.922.0 8.5%  
BALANCE SHEET DATA
Current assets Rs m29,28012,236 239.3%   
Current liabilities Rs m38,9123,461 1,124.5%   
Net working cap to sales %-16.641.3 -40.2%  
Current ratio x0.83.5 21.3%  
Inventory Days Days8460 140.1%  
Debtors Days Days5184 60.0%  
Net fixed assets Rs m55,71211,140 500.1%   
Share capital Rs m155177 87.3%   
"Free" reserves Rs m20,96820,237 103.6%   
Net worth Rs m26,26520,414 128.7%   
Long term debt Rs m17,16910 169,988.1%   
Total assets Rs m88,60624,486 361.9%  
Interest coverage x1.01,519.4 0.1%   
Debt to equity ratio x0.70 132,117.8%  
Sales to assets ratio x0.70.9 75.4%   
Return on assets %4.919.2 25.5%  
Return on equity %4.223.0 18.1%  
Return on capital %11.630.5 37.9%  
Exports to sales %37.80-   
Imports to sales %16.50-   
Exports (fob) Rs m21,933NA-   
Imports (cif) Rs m9,567NA-   
Fx inflow Rs m22,00411,667 188.6%   
Fx outflow Rs m11,7491,616 727.3%   
Net fx Rs m10,25510,052 102.0%   
CASH FLOW
From Operations Rs m8,0262,854 281.2%  
From Investments Rs m-1,744-2,604 67.0%  
From Financial Activity Rs m-4,447-2 222,370.0%  
Net Cashflow Rs m1,834248 739.4%  

Share Holding

Indian Promoters % 45.6 73.8 61.8%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 1.6 561.3%  
FIIs % 21.2 7.6 278.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 17.0 124.1%  
Shareholders   23,815 20,968 113.6%  
Pledged promoter(s) holding % 15.9 4.4 361.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   PLETHICO PHARMA  BIOCON LTD  FULFORD INDIA  ALKEM LABORATORIES  DIVIS LABORATORIES  

Compare JUBILANT LIFE SCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day in Green; Metal Stocks Top Gainers(Closing)

After opening the day in green, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Jun 20, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 8-QTR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS